In addition, several host defence peptides (also termed ‘small secreted antimicrobial peptides’) possess DNA-binding properties (reviewed in (238)), and among these, LL-37 has been reported at increased levels in plasma of COVID-19 patients (213, 214). This evidence concerns the gene CAMP and COVID-19.